CompletedNCT00996242
L-lysine added to treatment for schizophrenia
About this title
Read the official source — NCT00996242Medication studyAges 23–56Sweden
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 23 years to 56 years. Other eligibility criteria applied.
- Listed locations
- GothenburgSee all locations and recruitment
Study information
Study start dateSeptember 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Göteborg University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Sweden
- Age range
- From 23 Years to 56 Years
- Official registry ID
- NCT00996242
- Official title
Show the full official title
An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedGothenburg
Questions about this study
Who is behind this study?
The study sponsor is Göteborg University, a university.
Did this study involve medication?
Yes. The study involved medication, including L-lysine.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 23 years to 56 years. Other eligibility criteria applied.
Want to explore more studies?
Explore studiesRelated studies
A 28-week, randomised, open-label study evaluating the effectiveness of aripiprazole once-monthly versus paliperidone palmitate in adult patients with schizophrenia
A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease